Blog

Feb 12, 2020

Following the first U.S. test of CRISPR gene editing in patients with advanced cancer

Posted by in categories: bioengineering, biotech/medical

Following the first U.S. test of CRISPR gene editing in patients with advanced cancer, researchers report findings in Science that represent an important step toward the ultimate goal of using gene editing to help a patient’s immune system attack cancer. Read the research: https://fcld.ly/y1nst2o

Leave a reply